Australia and other high-quality "alternate geographies" offer advantages to a US-EU-centric pathway, especially in early development
Led by Steve Gourlay (MD) MBBS PhD MBA, Clinical Strategies draws on three decades of successful drug development and entrepreneurial finance spanning Australia, Europe, Israel and the US.
Providing services stretching from strategic program consulting to full service drug development, quality, reliability and responsiveness are our key values.
Principally directed towards strategy in small and large molecule development, Clinical Strategies can add value by enlarging the array of development and clinical trials options companies can choose from
Phase or goal-specific contract drug development taking your supplied materials and enacting the regulatory, clinical and reporting activities, with reporting tailored to your needs.